CRIS Current Research Information System

SAIA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.707
NA - Nord America 8.361
EU - Europa 6.640
AF - Africa 711
SA - Sud America 583
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 26.020
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.236
VN - Vietnam 2.989
SG - Singapore 2.529
CN - Cina 2.230
IT - Italia 1.265
GB - Regno Unito 1.168
DE - Germania 1.117
HK - Hong Kong 677
SE - Svezia 643
NL - Olanda 627
BR - Brasile 418
FR - Francia 415
IN - India 370
RU - Federazione Russa 269
KR - Corea 261
UA - Ucraina 258
IE - Irlanda 250
SC - Seychelles 164
JP - Giappone 160
CI - Costa d'Avorio 158
FI - Finlandia 143
ZA - Sudafrica 127
TG - Togo 113
BG - Bulgaria 94
EE - Estonia 85
NG - Nigeria 83
JO - Giordania 78
CA - Canada 70
AR - Argentina 66
CH - Svizzera 66
PH - Filippine 66
TH - Thailandia 52
BE - Belgio 43
PL - Polonia 42
AT - Austria 40
IQ - Iraq 38
MX - Messico 35
BD - Bangladesh 34
IR - Iran 29
TR - Turchia 28
TW - Taiwan 27
PK - Pakistan 25
ES - Italia 23
ID - Indonesia 23
SA - Arabia Saudita 20
CL - Cile 19
PY - Paraguay 19
EC - Ecuador 18
EG - Egitto 18
LT - Lituania 17
CO - Colombia 16
RO - Romania 15
AU - Australia 13
UZ - Uzbekistan 13
HR - Croazia 11
GR - Grecia 10
UY - Uruguay 10
MA - Marocco 9
MY - Malesia 9
DK - Danimarca 8
OM - Oman 8
PE - Perù 8
VE - Venezuela 8
KZ - Kazakistan 7
TN - Tunisia 7
KE - Kenya 6
JM - Giamaica 5
PT - Portogallo 5
SI - Slovenia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
IL - Israele 4
LV - Lettonia 4
MK - Macedonia 4
MN - Mongolia 4
NP - Nepal 4
SN - Senegal 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
HU - Ungheria 3
LB - Libano 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
ML - Mali 2
MM - Myanmar 2
MW - Malawi 2
PS - Palestinian Territory 2
TZ - Tanzania 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
Totale 25.996
Salva come PNG Salva come JPEG
Città #
Singapore 1.696
Ashburn 1.004
Southend 981
Ho Chi Minh City 702
Fairfield 641
Hong Kong 632
Chandler 624
Hanoi 616
San Jose 548
Hefei 494
Santa Clara 462
Frankfurt am Main 408
Eygelshoven 337
Wilmington 303
Woodbridge 299
Seattle 297
Houston 288
Beijing 278
Ann Arbor 268
Princeton 263
Dublin 249
Seoul 225
Cambridge 212
Boardman 210
Bologna 209
Dong Ket 205
Abidjan 157
Los Angeles 157
Lauterbourg 155
Jacksonville 146
New York 131
Tokyo 131
Lomé 113
Turin 112
Da Nang 106
Milan 106
Westminster 106
Berlin 99
Padova 94
Nanjing 92
Sofia 89
Helsinki 84
Abeokuta 80
Haiphong 80
Bremen 79
Amman 78
Buffalo 77
Munich 71
Bern 56
Jinan 54
San Diego 54
Redondo Beach 53
Rome 53
São Paulo 50
Changsha 49
Dallas 48
Guangzhou 47
Shenyang 47
Bengaluru 44
Saint Petersburg 42
Dearborn 41
Shanghai 41
Turku 41
Johannesburg 39
Brussels 38
Nanchang 37
Biên Hòa 34
Hebei 34
Tianjin 34
Council Bluffs 31
Hải Dương 30
Can Tho 29
London 28
Pune 28
The Dalles 28
Yubileyny 28
Falkenstein 27
Florence 27
Mülheim 27
Warsaw 26
Medford 25
Toronto 25
Phoenix 24
Quận Bình Thạnh 24
Bangkok 23
Ha Long 23
Paris 23
Chicago 22
Montreal 22
Nuremberg 22
Zhengzhou 22
Jiaxing 21
Olalla 21
Shenzhen 21
Taizhou 21
Vienna 21
Hangzhou 20
Falls Church 19
Mahé 19
Mountain View 19
Totale 16.476
Salva come PNG Salva come JPEG
Nome #
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 923
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 276
Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques 271
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 262
The role of the vascular surgeon in transcatheter aortic valve implantation 260
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 259
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 256
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 252
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 248
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 247
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction 245
[The HEAT-PPCI study] 242
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 239
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 230
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 226
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 225
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 223
La qualità di vita dopo impianto transcatetere di valvola aortica: revisione e valutazione critica della letteratura 222
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 221
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 217
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 214
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 214
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 210
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 205
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 202
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 202
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 199
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 198
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 197
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 195
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 195
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 193
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 192
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 190
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 189
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 188
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 187
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 186
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 182
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 182
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 182
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 181
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 181
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 180
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 180
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 179
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 179
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 178
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 177
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 176
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 176
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 175
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 175
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 173
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 173
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 170
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 169
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 168
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 168
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 168
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 167
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 167
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 166
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm 165
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 164
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 162
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 161
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 160
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 160
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 157
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 157
A rescue transcatheter solution for early sutureless basal ring infolding 156
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 156
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 156
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 155
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 155
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 153
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 153
Transcatheter Mitral Valve-in-Valve Dislocation: A Rescue Strategy 153
Twelve-Month Outcome of Patients with an Established Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting and Stratified by the Baseline Risk of Bleeding. Insights from the Warfarin and Coronary Stenting (War-Stent) Registry 153
[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy] 152
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 152
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 152
Transfemoral Transcatheter Aortic Valve Implantation at Hospitals Without On-Site Cardiac Surgery (TAVI at Home): A Multicenter Prospective Interventional Study 151
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 150
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 150
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 150
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 150
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 147
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 147
Correlation between aortic root dimension and coronary ectasia 146
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 145
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 143
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 142
The safety of drug-eluting stents. 142
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 141
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial 140
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery? 140
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves 139
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 139
Totale 19.066
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021753 0 0 0 0 0 0 0 0 0 84 66 603
2021/20222.336 179 116 132 202 182 119 46 155 80 203 505 417
2022/20233.095 270 438 165 379 251 227 75 183 575 84 271 177
2023/2024919 77 127 41 103 66 258 36 58 23 64 25 41
2024/20254.316 190 533 331 283 642 226 195 121 115 420 252 1.008
2025/202610.525 1.334 1.114 815 846 1.015 820 1.498 440 1.966 677 0 0
Totale 26.568